# Study on the Efficacy and Safety of Avatricopal in Patients With CLD Complicated With Thrombocytopenia

> **NCT06642740** · — · ENROLLING_BY_INVITATION · sponsor: **Beijing Ditan Hospital** · enrollment: 69 (estimated)

## Conditions studied

- Chronic Liver Disease
- Thrombopenia

## Interventions

- **OTHER:** Platelet count

## Key facts

- **NCT ID:** NCT06642740
- **Lead sponsor:** Beijing Ditan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-06-01
- **Primary completion:** 2025-06-01
- **Final completion:** 2025-06-01
- **Target enrollment:** 69 (ESTIMATED)
- **Last updated:** 2024-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06642740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06642740, "Study on the Efficacy and Safety of Avatricopal in Patients With CLD Complicated With Thrombocytopenia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06642740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*